gene therapies
IDNs Will Use AI, Other Tools To Improve Cell and Gene Therapies
Integrated delivery networks will be critical in improving access to cell and gene therapies in the coming years, ...
JUNE 16, 2025
Managed Care Pharmacies Urged to Prepare for Disruption
A new report outlines how the emergence of AI, growth of CGTs and significant regulatory changes are likely to ...
MAY 12, 2025
8 Trends to Watch in the Cell and Gene Therapy Market
An increase in rare/ultra-orphan treatments, along with a boom in cell and gene therapies and ambulatory infusion ...
DECEMBER 15, 2024
Managing the High Cost of Specialty Medications
Employers and health plans are concerned about managing high-ticket items such as cell and gene therapies, and ...
DECEMBER 14, 2024
Cell and Gene Therapy Surge Will Test Cold Chain Strength
A profusion of cell and gene therapies stored at extremely low temperatures will challenge every participant in the ...
DECEMBER 14, 2024
CGTs ‘a Big Deal for Pharmacy,’ So Getting Payment Right Is Crucial
At millions of dollars per dose, CGT treatments pose demanding procurement and reimbursement challenges for U.S. ...
JULY 17, 2024
Gene Therapy a Hot Trend in Cold Chain
More than 20 gene therapies are projected to be approved by the end of 2025, making it imperative that facilities ...
MAY 3, 2024
Who Will Pay for Sickle Cell Gene Therapy?
The December 2023 FDA approval of the first two gene therapies to treat sickle cell disease was a giant step ...
FEBRUARY 23, 2024
Despite Some Setbacks, Strong Specialty Pipeline Seen in 2024
2023 was a record year for new drug approvals, and while 2024 will probably not exceed that record, specialty ...
FEBRUARY 15, 2024
FDA Approves Casgevy for Beta-Thalassemia
The FDA approved the cell-based gene therapy Casgevy for transfusion-dependent beta-thalassemia.
JANUARY 18, 2024
Payors: Get Ready for More Gene Therapies
With three recombinant adeno-associated virus gene therapies approved by the FDA and several more in the pipeline, ...
OCTOBER 14, 2023
Stop-Loss Programs May Offset ‘Coming Tsunami’ of Gene Rx
In the era of increasingly high prices for some orphan drugs and for gene and cell therapies, health plans are ...
MAY 26, 2023
